GT199900004A - Comprimido de mesilato de trovafloxacino. - Google Patents

Comprimido de mesilato de trovafloxacino.

Info

Publication number
GT199900004A
GT199900004A GT199900004A GT199900004A GT199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A GT 199900004 A GT199900004 A GT 199900004A
Authority
GT
Guatemala
Prior art keywords
trovafloxacino
mesylate tablet
compositions
mesylate
tablet
Prior art date
Application number
GT199900004A
Other languages
English (en)
Inventor
Dale Johnson Alton
Christopher Michael Sinko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900004A publication Critical patent/GT199900004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES, ESPECIALMENTE EN FORMA DE COMPRIMIDOS, QUE CONTIENEN LA FORMA POLIMORFO II DEL MESILATO DE TROVAFLOXACINO, UN LUBRICANTE, Y CELULOSA MICROCRISTALINA (MC) COMO DILUYENTE. TALES COMPOSICIONES QUE EMPLEAN MC COMO DILUYENTES PRESENTAN BUENAS PROPIEDADES DE ESTABILIDAD DURANTE EL ALMACENAMIENTO Y DE DISOLUCION. ESTOS COMPUESTOS SE RELACIONAN CON LA ESTRUCTURA QUIMICA I, DESCRITA EN EL EXPEDIENTE.
GT199900004A 1998-01-21 1999-01-15 Comprimido de mesilato de trovafloxacino. GT199900004A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
GT199900004A true GT199900004A (es) 2000-07-08

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900004A GT199900004A (es) 1998-01-21 1999-01-15 Comprimido de mesilato de trovafloxacino.

Country Status (34)

Country Link
US (1) US6187341B1 (es)
EP (1) EP0930068A3 (es)
JP (1) JPH11269072A (es)
KR (1) KR100314977B1 (es)
CN (1) CN1227743A (es)
AP (1) AP1094A (es)
AR (1) AR012780A1 (es)
AU (1) AU758381B2 (es)
BG (1) BG103106A (es)
BR (1) BR9900116A (es)
CA (1) CA2259698C (es)
CO (1) CO4810225A1 (es)
DZ (1) DZ2712A1 (es)
EA (1) EA003247B1 (es)
GT (1) GT199900004A (es)
HR (1) HRP990023A2 (es)
HU (1) HUP9900154A3 (es)
ID (1) ID23735A (es)
IL (1) IL128051A0 (es)
IS (1) IS4947A (es)
MA (1) MA24747A1 (es)
NO (1) NO990243L (es)
NZ (1) NZ333838A (es)
OA (1) OA10958A (es)
PA (1) PA8466701A1 (es)
PE (1) PE20000169A1 (es)
PL (1) PL330981A1 (es)
SG (1) SG70666A1 (es)
SK (1) SK4299A3 (es)
TN (1) TNSN99007A1 (es)
TR (1) TR199900089A2 (es)
TW (1) TW518224B (es)
YU (1) YU2399A (es)
ZA (1) ZA99393B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101310T2 (tr) * 1998-11-10 2001-10-22 Bayer Aktiengesellschaft Farmasötik moksifloksasin preparatı.
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
AR025976A1 (es) * 1999-10-08 2002-12-26 Affinium Pharm Inc Inhibidores de fab i.
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
ES2518316T3 (es) 2002-12-06 2014-11-05 Debiopharm International Sa Compuestos heterocíclicos, métodos de fabricación de los mismos y su uso en terapia
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
EP1459739B1 (en) * 2003-03-19 2008-01-02 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
DK1828167T3 (da) 2004-06-04 2014-10-20 Debiopharm Int Sa Acrylamidderivater som antibiotiske midler
JP5046946B2 (ja) * 2004-10-15 2012-10-10 スパーナス ファーマシューティカルズ インコーポレイテッド 低乱用性薬学的製剤
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP3255045A1 (en) 2007-02-16 2017-12-13 Debiopharm International SA Salts, prodrugs and polymorphs of fab i inhibitors
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
AU2017223037B2 (en) 2016-02-26 2022-04-14 Debiopharm International S.A. Medicament for treatment of diabetic foot infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
KR100343909B1 (ko) * 1995-08-29 2003-04-10 화이자 인코포레이티드 트로바플록사신의쯔비터이온형태

Also Published As

Publication number Publication date
CO4810225A1 (es) 1999-06-30
TNSN99007A1 (fr) 2005-11-10
NZ333838A (en) 2000-03-27
TR199900089A3 (tr) 1999-10-21
NO990243L (no) 1999-07-22
HUP9900154A2 (hu) 1999-09-28
DZ2712A1 (fr) 2003-09-01
ID23735A (id) 2000-05-11
AU1217399A (en) 1999-08-12
BR9900116A (pt) 2000-05-02
AP9901443A0 (en) 1999-03-31
PA8466701A1 (es) 2000-09-29
AR012780A1 (es) 2000-11-08
NO990243D0 (no) 1999-01-20
EA199900046A2 (ru) 1999-08-26
SK4299A3 (en) 2000-06-12
KR100314977B1 (ko) 2001-11-24
TR199900089A2 (xx) 1999-10-21
HUP9900154A3 (en) 2000-12-28
OA10958A (en) 2001-10-31
KR19990068014A (ko) 1999-08-25
SG70666A1 (en) 2000-02-22
EP0930068A3 (en) 1999-12-22
IS4947A (is) 1999-07-22
MA24747A1 (fr) 1999-10-01
AP1094A (en) 2002-08-19
PL330981A1 (en) 1999-08-02
BG103106A (en) 1999-08-31
CN1227743A (zh) 1999-09-08
US6187341B1 (en) 2001-02-13
YU2399A (sh) 2002-06-19
EP0930068A2 (en) 1999-07-21
CA2259698C (en) 2003-04-15
HRP990023A2 (en) 1999-08-31
ZA99393B (en) 2000-07-21
CA2259698A1 (en) 1999-07-21
HU9900154D0 (en) 1999-03-29
EA199900046A3 (ru) 1999-12-29
JPH11269072A (ja) 1999-10-05
AU758381B2 (en) 2003-03-20
IL128051A0 (en) 1999-11-30
PE20000169A1 (es) 2000-03-10
TW518224B (en) 2003-01-21
EA003247B1 (ru) 2003-02-27

Similar Documents

Publication Publication Date Title
GT199900004A (es) Comprimido de mesilato de trovafloxacino.
ATE507212T1 (de) Morpholine als 5ht2c-agonisten
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
ATE312812T1 (de) Vanilloid-analoge die resiniferatoxin- pharmacophore enthalten als wirksame vanilloid rezeptor agonisten und analgetika, zusammensetzungen und ihre verwendung
AR054782A2 (es) Composiciones farmaceuticas y tabletas que contienen irbesartan en combinacion con un diuretico
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
DE60108236D1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
SE7412754L (sv) Dispenser med i forveg fuktade dukar
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
KR960704531A (ko) 장용성 과립 함유 정제(Enteric Granule-Containing Tablets)
CR20210007A (es) Degradadores selectivos del receptor de estrógeno
RU2008142261A (ru) Фармацевтическая композиция с модифицированным высвобождением и ее применение
AR019899A1 (es) Composicion farmaceutica y un procedimiento para prepararla.
KR970010764A (ko) 크로몬 유도체, 그의 제조방법 및 의약 조성물
RU2009106483A (ru) Огнезащитный состав
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
PT1273572E (pt) Piperazinas substituidas com tiofeno uteis no tratamento da hiperplasia prostatica benigna
ES2190574T3 (es) Nuevos compuestos del indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ECSP992822A (es) Comprimido de mesilato de trovafloxacina
ES377892A1 (es) Procedimiento para la preparacion de 10-piperazino-10,11 - dihidrodibenzo (b, f) tiepinas sustituidas en posicion 8.
UA92218C2 (ru) Способ получения стабильного при хранении биодизельного топлива
ES8302647A1 (es) Un procedimiento para la preparacion de guanidinas
GEP20084548B (en) New polysubstituted 1,1-pyridylamino-cyclo-propanamine compounds, a process for their preparation and pharmaceutical compositions containing them
ES2075688T3 (es) Agente de lavado liquido o pastoso.
MY117392A (en) Monocyclic compounds with four bifunctional residues having nk-2 antagonist action